Martine Zimmerman of Alexion on Europe’s regulatory process

In Orphan Drug Congress by Tim Peplow

Martine Zimmermann, Executive Director Global Regulatory Affairs at Alexion Pharmaceuticals, presented at World Orphan Drug Congress USA 2013 on the topic, ‘Where industry stumbles in Europe’s orphan drug regulatory process.’

World Orphan Drug Congress USA is the largest international, commercially-focused event for the advancement of rare disease research and orphan drug development. For more information on the 2014 event click here.